Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy

BJU International

Volumn 110, Issue 11 C, 2012, Pages

  Li, Tao ^a   Gui, Yaping ^a   Yuan, Tao ^a   Liao, Guoqiang ^a   Bian, Cuidong ^a   Jiang, Qiquan ^a   Huang, Shengsong ^a   Liu, Bo ^a   Wu, Denglong ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Biochemical recurrence; High mobility group box 1; Immunohistochemistry; Prostate cancer; Radical prostatectomy; Tissue microarray

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; PROSTATE SPECIFIC ANTIGEN; RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; CANCER CELL CULTURE; CANCER PATIENT; CANCER PROGNOSIS; CONTROLLED STUDY; FOLLOW UP; GENE OVEREXPRESSION; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAGING; SURVIVAL RATE; SURVIVAL TIME; TISSUE MICROARRAY; WESTERN BLOTTING; BIOSYNTHESIS; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHODOLOGY; MIDDLE AGED; PROGNOSIS; PROSTATE TUMOR; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; TUMOR CELL CULTURE; TUMOR RECURRENCE;

AGED; BLOTTING, WESTERN; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HMGB1 PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RNA, NEOPLASM; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

MLCS; MLOWN;

EID: 84873268694     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11277.x     Document Type: Article

References (30)

1. Zhang L , Wu S , Guo LR , Zhao XJ . Diagnostic strategies and the incidence of prostate cancer: reasons for the low reported incidence of prostate cancer in China . A sian J Androl 2009 ; 1 1 : 9-13
2. Almasi CE , Brasso K , Iversen P et al . Prognostic and predictive value of intact and cleaved forms of the urokinase plasminogen activator receptor in metastatic prostate cancer . Prostate 2011 ; 71 : 899-907
3. Bill-Axelson A , Holmberg L , Ruutu M et al . Radical prostatectomy versus watchful waiting in early prostate cancer . N Engl J Med 2005 ; 352 : 1977-84 (Pubitemid 40638368)
4. Freedland SJ , Humphreys EB , Mangold LA et al . Risk of prostate cancer-specifi c mortality following biochemical recurrence after radical prostatectomy . JAMA 2005 ; 294 : 433-9 (Pubitemid 41124175)
5. Molitierno J , Evans A , Mohler JL , Wallen E , Moore D , Pruthi RS . Characterization of biochemical recurrence after radical prostatectomy . Urol Int 2006 ; 77 : 130-4 (Pubitemid 44195772)
6. Ellerman JE , Brown CK , de Vera M et al . Masquerader: high mobility group box-1 and cancer . Clin Cancer Res 2007 ; 13 : 2836-48 (Pubitemid 46850704)
7. Stros M , Ozaki T , Bacikova A , Kageyama H , Nakagawara A . HMGB1 and HMGB2 cell-specifi cally downregulate the p53-and p73-dependent sequence-specifi c transactivation from the human Bax gene promoter . J Biol Chem 2002 ; 277 : 7157-64 (Pubitemid 34953105)
8. Lee H , Shin N , Song M et al . Analysis of nuclear high mobility group box 1 (HMGB1)-binding proteins in colon cancer cells: clustering with proteins involved in secretion and extranuclear function . J Proteome Res 2010 ; 9 : 4661-70
9. Kuniyasu H , Chihara Y , Kondo H , Ohmori H , Ukai R . Amphoterin induction in prostatic stromal cells by androgen deprivation is associated with metastatic prostate cancer . Oncol Rep 2003 ; 10 : 1863-8
10. Gnanasekar M , Thirugnanam S , Ramaswamy K . Short hairpin RNA (shRNA) constructs targeting high mobility group box-1 (HMGB1) expression leads to inhibition of prostate cancer cell survival and apoptosis . Int J Oncol 2009 ; 34 : 425-31
11. Tang D , Kang R , Zeh HJ , Lotze MT . High-mobility group box1 and cancer . Biochim Biophys Acta 2010 ; 1799 : 131-40
12. Kononen J , Bubendorf L , Kallioniemi A et al . Tissue microarrays for highthroughput molecular profi ling of tumor specimens . Nat Med 1998 ; 4 : 844-7 (Pubitemid 28331029)
13. Soumaoro LT , Uetake H , Higuchi T , Takagi Y , Enomoto M , Sugihara K . Cyclooxygenase-2 expression: a signifi cant prognostic indicator for patients with colorectal cancer . Clin Cancer Res 2004 ; 10 : 8465-71 (Pubitemid 40053411)
14. Shen X , Hong L , Sun H , Shi M , Song Y . The expression of high-mobility group protein box 1 correlates with the progression of non-small cell lung cancer . Oncol Rep 2009 ; 22 : 535-9
15. Park JS , Arcaroli J , Yum HK et al . Activation of gene expression in human neutrophils by high mobility group box 1 protein . Am J Physiol Cell Physiol 2003 ; 284 : C870-9 (Pubitemid 36336943)
16. Bonaldi T , Talamo F , Scaffi di P et al . Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion . EMBO J 2003 ; 22 : 5551-60 (Pubitemid 37279964)
17. Ulloa L , Messmer D . High-mobility group box 1 (HMGB1) protein: friend and foe . Cytokine Growth Factor Rev 2006 ; 17 : 189-201 (Pubitemid 43949075)
18. Uramoto H , Izumi H , Nagatani G et al . Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression . B iochem J 2003 ; 3 71 : 301-10 (Pubitemid 36547612)
19. Livesey KM , Tang D , Zeh HJ , Lotze MT . Not just nuclear proteins: ' novel'autophagy cancer treatment targets-p53 and HMGB1 . Curr Opin Investig Drugs 2008 ; 9 : 1259-63
20. Boonyaratanakornkit V , Melvin V , Prendergast P et al . High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells . Mol Cell Biol 1998 ; 18 : 4471-87 (Pubitemid 28343032)
21. Scaffi di P , Misteli T , Bianchi ME . Release of chromatin protein HMGB1 by necrotic cells triggers infl ammation . Nature 2002 ; 418 : 191-5 (Pubitemid 34773774)
22. Tian J , Avalos AM , Mao SY et al . Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE . Nat Immunol 2007 ; 8 : 487-96 (Pubitemid 46605917)
23. Yao X , Zhao G , Yang H , Hong X , Bie L , Liu G . Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma . J Cancer Res Clin Oncol 2010 ; 136 : 677-84
24. Sharma A , Ray R , Rajeswari MR . Overexpression of high mobility group (HMG) B1 and B2 proteins directly correlates with the progression of squamous cell carcinoma in skin . Cancer Invest 2008 ; 26 : 843-51
25. Sciarra A , Di Silverio F , Salciccia S , Autran Gomez AM , Gentilucci A , Gentile V . Infl ammation and chronic prostatic diseases: evidence for a link? Eur Urol 2007 ; 52 : 964-72 (Pubitemid 47332058)
26. Stock D , Groome PA , Siemens DR . Infl ammation and prostate cancer: a future target for prevention and therapy? Urol Clin North Am 2008 ; 35 : 117-30 (Pubitemid 350176596)
27. Ishiguro H , Nakaigawa N , Miyoshi Y , Fujinami K , Kubota Y , Uemura H . Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development . P rostate 2005 ; 6 4 : 92-100 (Pubitemid 40734743)
28. Shariat SF , Svatek RS , Kabbani W et al . Prognostic value of syndecan-1 expression in patients treated with radical prostatectomy . BJU Int 2008 ; 101 : 232-7 (Pubitemid 350294037)
29. Pound CR , Partin AW , Eisenberger MA , Chan DW , Pearson JD , Walsh PC . Natural history of progression after PSA elevation following radical prostatectomy . JAMA 1999 ; 281 : 1591-7 (Pubitemid 29211767)
30. Ferté C , André F , Soria JC . Molecular circuits of solid tumors: prognostic and predictive tools for bedside use . Nat Rev Clin Oncol 2010 ; 7 : 367-80